Global Regulatory Affairs Analyst & Consultant
Pharma · Medical Devices · SaMD · Life Sciences IT · Medical Coding · AI-Powered RA Research
USFDA · EU MDR/IVDR · MHRA · Health Canada · TGA · CDSCO · ICH · ISO 13485 · IEC 62304 · ISO 14971
Regulatory Affairs Professional · Life Sciences Consultant · AI Practitioner
I am a cross-functional Regulatory Affairs Analyst and Life Sciences Consultant with a unique combination of pharmaceutical sales leadership, NABH-accredited clinical hospital management, in-house corporate legal practice, and deep self-developed regulatory intelligence across USFDA, EU MDR/IVDR, MHRA, Health Canada, TGA, and CDSCO.
My pharma journey began with launching first-in-India branded APIs — Clopidogrel, Fenofibrate, LMWHs (Parnaparin), Esmolol, and Carvedilol — requiring deep knowledge of drug mechanisms, regulatory approved indications, labelling, and physician education.
As SBU Head at B.M. Birla Heart Research Centre (India's first NABH-accredited cardiac hospital), I collaborated extensively with medical device companies on coronary stents (BMS/DES), pacemakers, cath lab devices, and cardiac valves — gaining practical insight into Medical Device regulatory lifecycle.
I am certified in Medical Coding (ICD-10-CM, CPT, HCPCS, WHO-ICH, Modifiers) with applied CMS-1500 abstraction and RCM/AR management experience. My AI literacy includes daily use of Harvey AI, ChatGPT-4, Lexis Plus AI, and Power BI for regulatory research, predictive algorithm creation, and prompt engineering.
End-to-end regulatory knowledge across global jurisdictions, standards, and therapeutic areas
Direct links to all major regulatory agencies, databases, and submission portals referenced in professional practice
Technical standards central to global regulatory submissions across pharmaceuticals, medical devices, and SaMD
Quality Management System for Medical Devices — mandatory for device manufacturers globally
ISO 13485 →Medical Device Software — Software Lifecycle Processes. Class A/B/C safety classification framework
IEC 62304 →Application of Risk Management to Medical Devices — FMEA, hazard analysis, risk-benefit
ISO 14971 →Health Software — General Requirements for Product Safety. Extends IEC 62304 to all health software
IEC 82304-1 →Medical Devices — Usability Engineering — human factors, use error risk, formative & summative studies
IEC 62366 →Good Clinical Practice — international standard for clinical trial design, conduct, monitoring, reporting
ICH E6 R2 →Pharmaceutical Development · Quality Risk Management · Pharmaceutical Quality System
ICH Quality →Electronic Records and Electronic Signatures — FDA requirements for computer systems compliance
21 CFR 11 →Electronic Common Technical Document — global standard for regulatory submissions to FDA, EMA, MHRA
eCTD FDA →New FDA Quality Management System Regulation — effective Feb 2026, incorporates ISO 13485:2016
QMSR →GCP · GMP · GLP · GDP — Good Practices framework for clinical, manufacturing, laboratory, and distribution
GxP WHO →High-Risk AI classification for SaMD — dual compliance with EU MDR and AI Act starting 2026–2027
EU AI Act →Latest updates, analysis, and commentary on global pharmaceutical and medical device regulations
The FDA formally replaced the legacy Quality System Regulation with the Quality Management System Regulation — incorporating ISO 13485:2016 by reference. What this means for SaMD and medical device manufacturers globally.
The upcoming IEC 62304 Edition 2 replaces the three-class safety classification with a two-rigor-level model and expands scope to all health software, not just SaMD. Analysis of impact on existing QMS documentation.
From Harvey AI for regulatory document review to ChatGPT-4 for eCTD gap analysis and Power BI for submission tracking — practical applications of AI in regulatory affairs workflows with real efficiency benchmarks.
A practical walkthrough of the SUGAM portal for Form 40/10 submissions, CT-04, and the Medical Device Rules 2017 pathway — including common rejection reasons and how to avoid them.
New codes, revised guidelines, and cardiology-specific updates in ICD-10-CM FY2025 — essential for accurate CMS-1500 filing and faster reimbursement in cardiac device procedures and interventional cardiology.
Your next regulatory insight
Share analysis on FDA guidance updates, EU MDR changes, CDSCO circulars, new ICH guidelines, AI in RA, or medical coding updates.
Open to Regulatory Affairs Analyst, RA Consultant, Life Sciences IT, and Medical Device RA roles globally
📧 Emailesqaks@gmail.com
📞 Phone+91 62902 40024
📍 LocationSerampore, Kolkata, West Bengal, India
🌐 ModeOpen to Global Remote / Hybrid / Relocation
⚡ AvailableImmediately available
Target Roles
Regulatory Affairs Analyst · RA Consultant · RA Associate · Medical Device RA · SaMD Regulatory Specialist · Life Sciences IT RA · Medical Coding Specialist · RCM Analyst · Pharmacovigilance Analyst